|
Dec 18
|
OptimizeRx to Participate at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco
|
|
Dec 6
|
Wall Street Analysts Predict a 41.25% Upside in OptimizeRx Corp. (OPRX): Here's What You Should Know
|
|
Aug 24
|
OptimizeRx Expands AI Powered Omnichannel Platform
|
|
Aug 20
|
OptimizeRx Corporation (NASDAQ:OPRX) Analysts Just Trimmed Their Revenue Forecasts By 13%
|
|
May 4
|
Investing in OptimizeRx (NASDAQ:OPRX) five years ago would have delivered you a 114% gain
|
|
May 2
|
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
|